Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Chimeric Therapeutics Ltd. has announced the quotation of 555,009,026 fully paid ordinary shares on the Australian Securities Exchange (ASX), effective from December 9, 2024. This development is part of previously announced transactions and is set to enhance the trading activity of Chimeric’s shares, potentially attracting more investors. The move reflects the company’s strategic efforts to expand its market presence.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.